Intra-amniotic sildenafil treatment improves lung blood flow and pulmonary hypertension in congenital diaphragmatic hernia rats
Pulmonary hypertension associated with congenital diaphragmatic hernia (CDH) is a critical factor in determining prognosis. We propose that intra-amniotic sildenafil administration is an effective prenatal therapy for CDH-induced pulmonary hypertension. To assess the efficacy of this treatment, we a...
Main Authors: | Shiho Yoshida, Alexander M. Kreger, George K. Gittes |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-07-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2023.1195623/full |
Similar Items
-
VEGF receptor expression decreases during lung development in congenital diaphragmatic hernia induced by nitrofen
by: L. Sbragia, et al.
Published: (2014-02-01) -
Antenatal sildenafil administration to prevent pulmonary hypertension in congenital diaphragmatic hernia (SToP-PH): study protocol for a phase I/IIb placenta transfer and safety study
by: Francesca Maria Russo, et al.
Published: (2018-09-01) -
STATs in Lung Development: Distinct Early and Late Expression, Growth Modulation and Signaling Dysregulation in Congenital Diaphragmatic Hernia
by: Paulina Piairo, et al.
Published: (2017-12-01) -
Congenital diaphragmatic hernia; masquarding as hydropneumothorax
by: RP Yadav, et al.
Published: (2014-04-01) -
Right Bochdalek congenital diaphragmatic hernia: a tertiary center’s experience over 13 years
by: Alshaima Alghamdi, et al.
Published: (2021-05-01)